| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/17/2014 | WO2014056923A1 Vegf neutralizing prodrugs for the treatment of ocular conditions |
| 04/17/2014 | WO2014056915A1 Diagnosis, prevention and treatment of diseases of the joint |
| 04/17/2014 | WO2014056722A2 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
| 04/17/2014 | WO2014056590A1 Carboxylated polyamine derivatives as transfection reagents |
| 04/17/2014 | WO2014056304A1 Cisplatin complex and preparation method thereof |
| 04/17/2014 | WO2014056270A1 Targeting thymidine kinase photosensitizer and pharmaceutical composition and use for cancer treatment thereof |
| 04/17/2014 | WO2014026656A8 Nanofiber structure with immobilized organic agens and the method of its preparation |
| 04/17/2014 | WO2013067483A8 Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts |
| 04/17/2014 | WO2012112551A3 Compositions and methods for nutrient supplementation of ethanol-containing beverages |
| 04/17/2014 | US20140107738 Magnetic particles |
| 04/17/2014 | US20140107320 Blood coagulation protein conjugates |
| 04/17/2014 | US20140107316 Drug delivery conjugates containing unnatural amino acids and methods for using |
| 04/17/2014 | US20140107227 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 04/17/2014 | US20140107226 Methods for enhancing stability of polyorthoesters and their formulations |
| 04/17/2014 | US20140107224 Generation of therapeutic microfoam |
| 04/17/2014 | US20140107209 Formulations of low dose diclofenac and beta-cyclodextrin |
| 04/17/2014 | US20140107203 Pharmaceutical semi-solid composition of isotretinoin |
| 04/17/2014 | US20140107197 Pharmaceutical composition |
| 04/17/2014 | US20140107195 Water-swellable polymers |
| 04/17/2014 | US20140107173 Compositions and Methods for Treatment of Glaucoma |
| 04/17/2014 | US20140107169 Parenteral formulation for epothilone analogs |
| 04/17/2014 | US20140107159 Compositions and methods of forming films for improved drug delivery |
| 04/17/2014 | US20140107146 Abuse-resistant controlled-release opioid dosage form |
| 04/17/2014 | US20140107145 Compositions for drug administration |
| 04/17/2014 | US20140107130 Oral Solution Formulations of Aripiprazole |
| 04/17/2014 | US20140107088 Medical devices and methods comprising an anabolic agent for treatment of an injury |
| 04/17/2014 | US20140107081 Salicylic acid topical formulation |
| 04/17/2014 | US20140107071 Methods of manufacturing topical compositions and apparatus for the same |
| 04/17/2014 | US20140107062 Compositions and methods for treating or preventing diseases of body passageways |
| 04/17/2014 | US20140107047 Cosmetic compositions for increasing bioavailability of active compounds |
| 04/17/2014 | US20140107043 New conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanionic polypeptide for the treatment of aids |
| 04/17/2014 | US20140107039 Polycomb repressive complex 2 (prc2) inhibitors and uses thereof |
| 04/17/2014 | US20140106450 Compositions and Methods for Inhibiting Expression of a Target Gene |
| 04/17/2014 | US20140105995 Silk fibroin systems for antibiotic delivery |
| 04/17/2014 | US20140105993 Modified-release microparticles based on amphiphilic copolymer and on active principle(s) and pharmaceutical formulations comprising them |
| 04/17/2014 | US20140105992 Vaccine |
| 04/17/2014 | US20140105989 Treatment Methods with Low-Dose, Longer-Acting Formulations of Local Anesthetics and Other Agents |
| 04/17/2014 | US20140105987 Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
| 04/17/2014 | US20140105986 Topical compositions |
| 04/17/2014 | US20140105985 Topical use of levofloxacin for reducing lung inflammation |
| 04/17/2014 | US20140105984 Reduction of flake-like aggregation in nanoparticulate active agent compositions |
| 04/17/2014 | US20140105977 Gastric retentive extended release pharmaceutical compositions |
| 04/17/2014 | US20140105975 Film coating for tablets and caplets |
| 04/17/2014 | US20140105968 Transpulmonary liposome for controlling drug arrival |
| 04/17/2014 | US20140105963 Topical nitric oxide systems and methods of use thereof |
| 04/17/2014 | US20140105960 Hydrogels for tissue regeneration |
| 04/17/2014 | US20140105957 Bis-(alpha-amino-diol-diester) containing polyesteramide for ophtamology |
| 04/17/2014 | US20140105935 Opsonized beta-glucan preparation and methods |
| 04/17/2014 | US20140105922 Variant Target Binding Agents and Uses Thereof |
| 04/17/2014 | US20140105921 Prodrugs of Peptide Epoxy Ketone Protease Inhibitors |
| 04/17/2014 | US20140105920 Compositions and methods to treat disease characterized by cellular proliferation and angiogenesis |
| 04/17/2014 | US20140105896 Fibronectin based scaffold domain proteins that bind to myostatin |
| 04/17/2014 | US20140105891 Treatment of cancer |
| 04/17/2014 | US20140105888 Novel modulators and methods of use |
| 04/17/2014 | US20140105884 Material and method for treating internal cavities |
| 04/17/2014 | US20140105883 Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, Renovascular and Retinovascular Circulatory Beds |
| 04/17/2014 | US20140105882 Therapeutic composition with a botulinum neurotoxin |
| 04/17/2014 | US20140105880 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| 04/17/2014 | US20140105865 Preventing diseases in infants delivered via caesarean section |
| 04/17/2014 | US20140105864 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres |
| 04/17/2014 | US20140105858 Ifn-beta compositions, preparation methods and uses thereof |
| 04/17/2014 | US20140105857 Compositions and methods for enhancing active agent absorption |
| 04/17/2014 | US20140105852 Cross-linked polysaccharide composition |
| 04/17/2014 | US20140105830 Abuse-proofed dosage form |
| 04/17/2014 | US20140105828 Nanoparticles caring nucleic acid cassettes for expressing rna |
| 04/17/2014 | US20140105817 Composition and Delivery Vehicle for Active Agents and Methods Therefor |
| 04/16/2014 | EP2719706A1 Bispecific HER2 ligands for cancer therapy |
| 04/16/2014 | EP2719398A2 Medical tissue-marker and manufacturing method for same |
| 04/16/2014 | EP2719377A1 Method for producing orodispersible tablets |
| 04/16/2014 | EP2719375A1 Cannabinoids for the treatment of cancers dependent on hedgehog mechanisms |
| 04/16/2014 | EP2719374A1 Drug delivery device |
| 04/16/2014 | EP2718374A1 Core-shell microspheres |
| 04/16/2014 | EP2718331A1 N,n,n-trialkylpolymers, methods of their preparation and uses thereof |
| 04/16/2014 | EP2718316A1 Polypeptides |
| 04/16/2014 | EP2718315A2 Polypeptides |
| 04/16/2014 | EP2718314A2 Polypeptides |
| 04/16/2014 | EP2717920A2 Activatable nanoprobes for intracellular drug delivery |
| 04/16/2014 | EP2717919A1 Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
| 04/16/2014 | EP2717918A2 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate |
| 04/16/2014 | EP2717917A1 P97-antibody conjugates and methods of use |
| 04/16/2014 | EP2717916A1 Protein-polymer-drug conjugates |
| 04/16/2014 | EP2717915A1 Composition for oral delivery of biologically-active substances |
| 04/16/2014 | EP2717914A2 Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
| 04/16/2014 | EP2717862A2 Compositions for encapsulating biomaterials and uses related thereto |
| 04/16/2014 | EP2717857A1 Method for the synthesis of porphyrin-phospholipid conjugates |
| 04/16/2014 | EP2717856A2 Ceramide anionic liposome compositions |
| 04/16/2014 | EP2717854A1 Treatment of cancers and metastases with suspensions of cilengitide in carrier |
| 04/16/2014 | EP2717853A1 Gel compositions |
| 04/16/2014 | EP2717768A1 Electrode sensor kit, electrode assembly, and topical preparation for establishing electrical contact with skin, use thereof, and method of electro-impedance tomography (eit) imaging using these |
| 04/16/2014 | EP2717702A1 Process for the preparation of a metal complex in an oily organic matrix |
| 04/16/2014 | EP2717699A1 Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents |
| 04/16/2014 | CN103732746A Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia |
| 04/16/2014 | CN103732617A Improved peptide pharmaceuticals for insulin resistance |
| 04/16/2014 | CN103732616A A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof |
| 04/16/2014 | CN103732257A Bio-orthogonal drug activation |
| 04/16/2014 | CN103732256A Bio-orthogonal drug activation |
| 04/16/2014 | CN103732255A Soft capsule pharmaceutical preparation, composition for soft capsule pharmaceutical preparation, and method for producing soft capsule pharmaceutical preparation |
| 04/16/2014 | CN103732254A Packaged dianhydrohexitols having high chemical stability |
| 04/16/2014 | CN103732246A Method for preparing multiple antigen glycopeptide carbohydrate conjugates |
| 04/16/2014 | CN103732227A Pharmaceutical composition containing diamine derivative |